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Abstract
Background: Perceived sleep quality may play an important role in diagnosis and therapy for obstructive sleep apnea
(OSA). However, few studies have assessed factors that are associated with perceived sleep quality in OSA patients.
Hypoxemia depresses the central nervous system and attenuates the perceived respiratory load in asthmatic patients.
This study aimed to investigate the factors related to perceived sleep quality, focusing on the role of hypoxemia.
Methods: Polysomnography studies of 156 OSA patients were reviewed. Traditional polysomnographic parameters,
including parameters of oxy-hemoglobin saturation (SpO2), were calculated, and the sleep questionnaire and scales
were used. Considering the possible pitfalls of absolute values of SpO2 and individualized responses to hypoxemia, the
amplitude of desaturation was further computed as “median SpO2 minus lowest 5 % SpO2 “and “highest 5 % SpO2
minus median 5 % SpO2”. Correlations between these parameters and perceived sleep quality, represented as the
Pittsburgh sleep quality index (PSQI), were performed. Multiple linear regression analysis was also conducted to
investigate the factors associated with the PSQI.
Results: Although the PSQI was not correlated with the apnea-hypopnea index (r = −0.113, p = 0.162) and oxygen
desaturation index (r = −0.085, p = 0.291), the PSQI was negatively correlated with “median SpO2 minus lowest 5 %
SpO2” (r = −0.161, p = 0.045). After adjusting for age, total sleep time, the periodic limb movements index, tendency of
depression, and the lowest 5 % SpO2, the “median SpO2 minus lowest SpO2” was still a significant predictor for a lower
PSQI (β = −0.357, p = 0.015).
Conclusions: More severe hypoxemia is associated with better perceived sleep quality among OSA patients. This
paradox may be associated with hypoxemia-related impairment of perception. The effect of hypoxemia did not
appear to be significant in relatively mild hypoxemia but become significant in severe hypoxemia.” Median SpO2
minus lowest 5 % SpO2” may also be a better predictor of perceived sleep quality than the apnea-hypopnea index
because of the disproportionate effects of hypoxemia. Additionally, further studies are necessary to confirm the role of
hypoxemia on perceived sleep quality and identify the possible threshold of hypoxemia in OSA patients.
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Background
Obstructive sleep apnea (OSA) is characterized by re-
petitive cessation of breathing with preserved ventilatory
effort during sleep. OSA is common in the general
population, with a prevalence of 24 % in men and 9 % in
women [1]. The prevalence of OSA has increased in the
last two decades [2]. OSA has been shown to be associ-
ated with excessive daytime sleepiness, poor attention,
impaired cognitive function, and increased cardiovascu-
lar risks [3, 4]. Even though undiagnosed OSA results in
potential health risks and increases the socio-economic
burden [5], 82–93 % of OSA remains clinically undiag-
nosed [6]. Because only 15.5–22.6 % of OSA patients can
subjectively identify symptoms that lead them to seek
medical assistance, misperception of sleep quality may
play a crucial role in undiagnosed OSA [1]. Additionally,
misperception of sleep quality may further reduce the
motivation to have continuous positive airway pressure
(CPAP) therapy. Conversely, pre-CPAP health belief-
modifying interventions can improve compliance to
CPAP [7–9]. Although perception of sleep quality is
important in diagnosis and therapy of OSA, few studies
have examined factors associated with perception of
sleep quality in OSA patients.
Hypoxemia, one of the main presentations of OSA, de-
presses the central nervous system, and attenuates the per-
ception of respiratory load and dyspnea in severe asthmatic
patients. Hypoxemia may also delay the reaction time of
the nervous system after thermal, visual, and auditory
stimulation [10, 11]. In addition, hypoxemia can stimulate
inhibitory neurotransmitters, such as endogenous opioids,
adenosine, and gamma-aminobutyric acid. These neuro-
transmitters may be responsible for a depressed response
of the central nervous system and attenuated perception
[12, 13]. However, whether hypoxemia may also be related
to attenuated perception of sleep quality in OSA patient is
still unclear.
Because perception of sleep quality is subjective and dif-
ficult to quantify, a well-established and self-rated ques-
tionnaire may be an appropriate way of measurement. The
Pittsburgh sleep quality index (PSQI) has been extensively
used in a variety of populations. The internal homo-
geneity, consistency, validity, sensitivity, and specificity
of the PSQI are acceptable [14]. The PSQI has been
used in several psychometric studies, including in
patients with bone marrow transplant, renal transplant,
breast cancer, benign breast problems, and primary
insomnia [15, 16]. Moreover, the PSQI is also used as
a surrogate of perception of sleep quality in patients
of chronic fatigue syndrome, myasthenia gravis, de-
mentia, healthy women, and even in patients with
OSA [17–21].
Therefore, this retrospective study was conducted to in-
vestigate factors that are associated with the perception of
sleep quality by analyzing the PSQI, focusing on the role
of hypoxemia, in OSA patients.
Methods
Patients
Records of patients who were referred to the Sleep Center
of Kaohsiung Medical University Hospital for their first
diagnosis of OSA between January 2009 and December
2011 were reviewed. This study was approved by the Insti-
tutional Review Board of Kaohsiung Medical University
Hospital (KMUH-IRB-20120136). Because of the nature
of retrospective design in this study, no informed consent
was available.
Patients with an apnea-hypopnea index (AHI) ≥ 5 per
hour and a diagnosis of OSA were enrolled. Those with
other concurrent sleep diseases, including periodic limb
movement disorder, restless leg syndrome, rapid eye move-
ment behavior disorder, and narcolepsy were excluded. Pa-
tients with known medical or neurological diseases that
might disturb sleep quality (i.e., congestive heart failure,
asthma, chronic obstructive pulmonary disease, chronic
kidney disease, liver cirrhosis, severe osteoarthritis, malig-
nancy, dementia, Parkinsonism, or disabling stroke) were
also excluded. All of the patients underwent one over-
night full-channel polysomnography (PSG) and com-
pleted sleep questionnaire and scales in terms of the
Chinese versions of the Epworth sleepiness scale (ESS),
the PSQI, the short form-36 (SF-36), and either the
Center for Epidemiologic Studies Depression Scale
(CES-D) or the Hospital Anxiety and Depression Scale
(HADS) before receiving PSG. This study was approved
by the Institutional Review Board of Kaohsiung Medical
University Hospital (KMUH-IRB-20120136).
Polysomnography
The overnight full-channel PSG was recorded by two vali-
dated machines (Respironic Alice 5 or Nicolet Ultrasom),
including six referential channels of an electroencephalo-
gram (EEG): F3-A2, F4-A1, C3-A2, C4-A1, O1-A2, O2-A1,
two channels of an electrooculogram recorded on bilateral
canthi, and three channels of an electromyogram recorded
on the submentalis and bilateral tibialis anterior muscles.
Nasal airflow was recorded by a thermistor and a nasal
airway pressure transducer. Respiratory effort was re-
corded by thoracic and abdominal respiratory inductive
plethysmography. Oxyhemoglobin saturation (SpO2) was
recorded by pulse oximetry and the probe was placed on
the patient’s index finger.
Sleep stages and sleep-related events were scored
based on the criteria of the American Academy of Sleep
Medicine [22]. EEG arousal was defined as at least 3 sec-
onds of an abrupt shift in EEG frequency that was pre-
ceded by at least 10 seconds of sleep on any of the
referential EEG channels. The frequency of arousals was
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represented as the arousal index (AI) which was calcu-
lated by arousal events per hour of total sleep time.
Apnea was defined as a drop in the peak thermal sen-
sory excursion by more than 90 % of baseline lasting at
least 10 seconds. Hypopnea was defined as a decrease in
airflow either by ≥ 30 % of baseline associated with at
least 4 % of desaturation, or ≥ 50 % of baseline, accom-
panied by arousal or ≥ 3 % of desaturation from the pre-
event baseline.
The AHI was calculated by the number of apnea and
hypopnea events per hour of total sleep time. The oxygen
desaturation index (ODI) was calculated by the number of
desaturation events ≥ 4 % compared with baseline divided
by the total sleep time. Other respiratory event-related pa-
rameters, including mean saturation (mean SpO2) and
minimum saturation (mini SpO2) were also analyzed. The
time spent with saturation < 90 % (T90) was defined as the
total duration (seconds) of desaturation with SpO2 < 90 %
per hour of total sleep time.
An episode of leg movement (LM) was defined as an
increase in amplitude of an electromyogram greater than
8 μV from baseline for 0.5–10 seconds. More than four
consecutive LMs with a 5–90 second interval between
the start of two LMs was defined as periodic limb move-
ments in sleep (PLMS). The periodic limb movements
index (PLMI) was calculated by dividing the total events
of PLMS by the total sleep time (hours).
Sleep questionnaire and scales
All of the patients completed validated sleep question-
naires and sleep scales using the Chinese versions of the
ESS, PSQI, SF-36, and either the CES-D or HADS. The
ESS comprises eight items, with a total score of 0–24,
where a higher ESS score indicates worse daytime
sleepiness [23]. The PSQI consists of nine items with a
total score of 0–21 and seven sub-scores in terms of (1)
subjective sleep quality, (2) sleep latency, (3)sleep dur-
ation, (4) habitual sleep efficiency, (5) sleep disturb-
ance, (6) use of hypnotics, and (7) daytime dysfunction.
A higher PSQI score indicates worse subjective sleep
quality [24].
The SF-36 is a self-rated scale that is widely used for
assessing health-related quality of life. The SF-36 con-
sists of eight subscales, including physical functioning,
role physical, role emotion, vitality, mental health, social
functioning, body pain, and general health. Each item is
scored from 0–100 and integrated into two summary
measures, the physical and mental component scores of
the SF-36 (SF-36 physical and SF-36 mental). Higher
scores in the SF-36 indicate better health-related quality
of life [25]. The CES-D, designed to evaluate the pa-
tient’s tendency of depression, contains 20 subscales,
with each score ranging from 0–4. Higher scores suggest
a higher possibility of depression [26].
Finally, the HADS is a self-administered 14-item scale
which is used to investigate the level of anxiety and de-
pression. The HADS is divided into the HADS-anxiety
(HADS-A) and HADS-depression (HADS-D). Each part
contains seven subscales with a score ranging from 0–3.
Higher scores indicate a greater tendency of anxiety or de-
pression. Depression was defined in this study if either the
CES-D score was ≥ 15 or the HADS-D score was ≥ 8 [27].
Saturation-related parameters
Signals of SpO2, sampled at 1 Hz by pulse oximetry,
were analyzed by Matlab. Artifacts, defined as an
abrupt change in SpO2 > 4 % compared with baseline
(one second before the artifact), were excluded and re-
placed with SpO2 one second before the artifact [28].
SpO2 values were further rearranged from lowest to
highest to establish an SpO2 series. The median value
of the SpO2 series (median SpO2), the average value of
the lowest 5 % of the SpO2 series (lowest 5 % SpO2),
and the average value of the highest 5 % of the SpO2
series (highest 5 % SpO2) were calculated. Furthermore,
the amplitude of desaturation was computed based on
the difference between the highest 5 % SpO2 and the
median 5 % SpO2 (highest 5 % SpO2 minus median 5 %
SpO2), as well as the difference between the median
SpO2 and the lowest 5 % SpO2 (median SpO2 minus
lowest 5 % SpO2).
Statistical analysis
Statistical analysis was performed by JMP version 9 (SAS
Institutes Inc, Cary, NC, USA). Continuous variables (i.e.,
age, PSG parameters, sleep questionnaire/scales, and
saturation-related parameters) are shown as mean ± stand-
ard deviation (SD). Binary variables (sex) are shown as the
number of patients and percentage. The Student’s t-test
was used to compare the PSQI between men and women.
Pearson’s correlation was used to assess the relationships
among demographic variables, PSG parameters, sleep
questionnaire/scales, saturation-related parameters, and
the PSQI.
Mixed model stepwise multiple linear regression analysis
was performed to determine factors associated with the
PSQI. Candidate variables were chosen to be entered into
multivariable analysis if p <0.2 was identified in Pearson’s
correlation analysis and the Student’s t test. Determination
of collinearity was performed by the attached software from
JMP by which the variance proportion, the eigenvalue, and
the condition index were available. Collinearity of these
variables was decided if the condition number, defined as
the maximum of the condition index, was more than 30. If
collinearity was identified, centering was conducted. The
entered variables were presented with their coefficient (β),
95 % confidence interval (95 % CI), and p value after
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adjusting for other confounding variables. Statistical signifi-
cance was set at p < 0.05.
Results
Of 325 patients, 247 who fulfilled the inclusion criteria
were enrolled. Based on a chart review, 91 patients with
other concurrent sleep disorders or known medical or
neurological disease were excluded. The remaining 156
patients were included in the final analysis.
Baseline data
Table 1 shows the baseline demographic characteristics
of all OSA patients. The 156 OSA patients included 118
(75.6 %) men and 38 (24.4 %) women. The mean (±SD)
age was 47.3 ± 14.0 years. The mean (±SD) of AHI, ODI,
mean SpO2, mini SpO2, and T90 were 35.0 ± 25.9/h,
30.7 ± 24.7/ h, 94.7 % ± 2.4 %, 77.5 ± 10.4 %, and 445.6 ±
571.5 s/h, respectively. The mean (±SD) of total sleep
time, sleep efficiency, and AI were 355.0 ± 61.8 minutes,
83.2 ± 12.6 %, and 31.8 ± 23.4/h, respectively. The mean
(±SD) PSQI was 9.4 ± 4.3, and the mean (±SD) ESS was
11.2 ± 5.3. According to either the CES-D or the HADS-
D, 46.8 % of patients had a tendency for depression.
Univariate analysis
The PSQI was not significantly different between men and
women (mean:9.1; 95 % CI :8.36–9.85 vs. mean:10.32;
95 % CI:8.73–11.90, p = 0.129). Table 2 shows the relation-
ship between the PSQI and age, body mass index, trad-
itional PSG parameters, sleep questionnaire and scales,
and saturation-related variables. There were signifi-
cantly positive correlations between the PSQI and
age (r = 0.209, p = 0.009), ESS (r = 0.274, p < 0.001),
CES-D (r = 0.372, p = 0.026), and HADS-D (r = 0.257,
p = 0.005).
There were significantly negative correlations between
the PSQI and total sleep time (r = −0.235, p = 0.003),
sleep efficiency (r = −0.195, p = 0.015), and the SF-36
physical and the SF-36 mental (r = −0.394, p < 0.001 and
r = −0.445, p < 0.001, respectively). However, there were
no significant correlations between the PSQI and the
AHI, ODI, mean SpO2, mini SpO2, or T90.
When we analyzed the relationships between the PSQI
and saturation-related parameters, there were still no
significant correlations between the PSQI and median
SpO2, lowest 5 % SpO2, highest 5 % SpO2, and “highest
5 % SpO2 minus median SpO2”. The PSQI did correlate
negatively with “median SpO2 minus lowest 5 % SpO2”
(r = −0.161, p = 0.045).
Multivariable analysis
By mixed model stepwise multiple linear regression ana-
lysis (Table 3), the larger“median SpO2 minus lowest 5 %
SpO2” value was still significantly associated with a lower
PSQI(β = −0.357; 95 % CI: −0.644– -0.070, p = 0.015) after
adjusting for age, total sleep time, PLMI, tendency of de-
pression, and lowest 5 % SpO2.
Discussion
This study showed that there was no significant correl-
ation between the PSQI total score and traditional PSG
parameters, including the AHI and ODI. Nonetheless,
Table 1 Demographic characteristics of OSA patients
Characteristics, (n = 156) Mean (SD)
Gender-male (n, %) 118 (75.6 %)
Age(years) 47.3(14.0)
BMI (Kg/m2) 27.3 (4.5)
Total sleep time (min) 355.0(61.8)
Sleep efficiency(%) 83.2(12.6)
Sleep latency(min) 14.3(19.7)
Stage I (%) 23.8(19.4)
Stage II (%) 51.3(13.5)
Stage III (%) 11.3(10.4)
Stage REM (%) 13.5(6.7)
AHI (/hour) 35.0(25.9)
Mean SpO2 (%) 94.7(2.4)
Mini SpO2 (%) 77.5(10.4)
ODI (/hour) 30.7(24.7)
T90 (second/hour) 445.6(571.5)




SF-36 physical (scale) 46.8(9.2)
SF-36 mental (scale) 41.3(11.6)
CESD (n = 36) 18.0(11.0)
HADS-depression(n = 120) 6.5(3.8)
Median SpO2 (%) 94.9(2.6)
Lowest 5 % SpO2 (%) 81.4(9.4)
Highest 5 % SpO2 (%) 98.2(0.9)
Hightest 5 % SpO2 minus Median SpO2 3.28(2.28)
Median SpO2 minus Lowest 5 % SpO2 (%) 13.5(8.3)
Abbreviations: BMI body mass index; REM rapid eye movement sleep; AHI
apnea-hypopnea index; Mean SpO2 mean saturation of total time in bed; Mini
SpO2 minimum saturation of total time in bed; ODI oxygen desaturation index;
T90 time spent with saturation < 90 %; PLMI periodic leg movement index;
PSQI Pittsburgh sleep quality index; ESS Epworth sleepiness scale; SF-36 Physical,
physical component score of short form 36; SF-36 Mental, mental component
score of short form 36; CESD center for epidemiologic studies depression scale;
HADS-depression depression component of Hospital Anxiety and Depression Scale;
median SpO2 the median value of saturation of total sleep time; Lowest 5 % SpO2
averaged value from the lowest 5 % saturation of total sleep time; Highest 5 %
SpO2, averaged value from the highest 5 % saturation of total sleep time; Highest%
SpO2 minus Medium SpO2, the difference between Highest 5 % SpO2 and Medium
SpO2; Median SpO2 minus Lowest 5 % SpO2, the difference between Median SpO2
and Lowest 5 % SpO2
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the amplitude of desaturation in terms of “median SpO2
minus lowest 5 % SpO2” was a significant predictor for a
lower PSQI total score although “highest 5 % SpO2
minus median SpO2” was not correlated with the PSQI.
These findings suggest that OSA patients with more se-
vere hypoxemia paradoxically feel that they have better
sleep quality. Moreover, the effect of hypoxemia on per-
ceived sleep quality was not significant in relatively mild
hypoxemia, but appeared to become remarkable in se-
vere hypoxemia.
Perception of sleep, a complicated process of cogni-
tion, involves several subjective experiences, including
sensory and visual imagery, affect, and reality orienta-
tion. Three other types of cognition, including thought
control, awareness of surroundings, and temporal
awareness, are significantly correlated with subjective
Table 2 Correlation between PSQI-total score and age, body mass index, traditional parameters of polysomnography, sleep
questionnaire and scales, and saturation-related variables (n = 156)
Variables Correlation Lower 95 % Upper 95 % p-value
Demographic data
Age(years) 0.209 0.054 0.355 0.009*
BMI (Kg/m2) 0.021 −0.137 0.177 0.796
Parameters of PSG
Total sleep time (min) −0.235 −0.379 −0.081 0.003*
Sleep efficiency(%) −0.195 −0.342 −0.039 0.015*
Sleep latency(min) 0.114 −0.044 0.267 0.156
Stage I (%) 0.050 −0.108 0.206 0.533
Stage II (%) 0.001 −0.156 0.158 0.992
Stage III (%) −0.077 −0.231 0.081 0.339
Stage REM (%) −0.016 −0.172 0.142 0.846
AHI (/hour) −0.113 −0.265 0.045 0.162
Mean SpO2 (%) 0.016 −0.142 0.172 0.846
Mini SpO2 (%) 0.084 −0.075 0.238 0.300
ODI (/hour) −0.085 −0.239 0.073 0.291
T90 (second/hour) −0.069 −0.223 0.090 0.396
Arousal index (/hour) −0.023 −0.179 0.135 0.778
PLMI (/hour) 0.146 −0.011 0.296 0.069
Questionnaire
ESS 0.274 0.122 0.413 <0.001*
SF-36 physical −0.394 −0.519 −0.253 <0.001*
SF-36 mental −0.445 −0.563 −0.310 <0.001*
CESD (n = 36) 0.372 0.049 0.624 0.026*
HADS-depression (n = 120) 0.257 0.081 0.418 0.005*
Saturation-related parameters
Median SpO2 −0.096 −0.249 0.062 0.235
Lowest 5 % SpO2 0.115 −0.043 0.267 0.154
Highest 5 % SpO2 −0.149 −0.299 0.008 0.063
Highest % SpO2 minus 0.051 −0.107 0.206 0.526
Median SpO2
Median SpO2 minus Lowest 5 % SpO2 −0.161 −0.310 −0.004 0.045*
*p < 0.05
Abbreviations: BMI body mass index; REM rapid eye movement sleep; AHI apnea-hypopnea index; Mean SpO2 mean saturation of total time in bed; Mini SpO2 minimum
saturation of total time in bed; ODI oxygen desaturation index; T90 time spent with saturation < 90 %; PLMI periodic leg movement index; ESS Epworth sleepiness scale;
SF-36 Physical physical component score of short form 36; SF-36 Mental mental component score of short form 36; CESD center for epidemiologic studies depression
scale; HADS-depression depression component of Hospital Anxiety and Depression Scale; median SpO2 the median value of saturation of total sleep time; Lowest 5 %
SpO2 averaged value from the lowest 5 % saturation of total sleep time; Highest 5 % SpO2 averaged value from the highest 5 % saturation of total sleep time; Highest%
SpO2 minus Medium SpO2 the difference between Highest 5 % SpO2 and Medium SpO2; Median SpO2 minus Lowest 5 % SpO2 the difference between Median SpO2
and Lowest 5 % SpO2
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estimation of physiological sleep states [29]. Many areas
in the brain, including the thalamus, hypothalamus, cin-
gulate gyrus, right insula, and temporal, inferior par-
ietal, and frontal lobes, are involved in the perception of
sleep [29, 30]. Most of these areas are also involved in
OSA patients, as supported by neuro-imaging studies.
High-resolution magnetic resonance imaging by voxel-
based morphometry shows gray matter loss in the frontal,
temporal, and parietal lobes, the anterior cingulate gyrus,
the hippocampus, and the cerebellum in patients with
OSA [31]. Functional magnetic resonance imaging dem-
onstrates decreased brain activation in the frontal and par-
ietal lobes, insula, and cingulate gyrus [32], while single
photon emission computerized tomography shows signifi-
cantly reduced regional cerebral blood flow in the bilateral
para-hippocampal gyri, right lingual gyrus, peri-central
gyrus, and cuneus in OSA patients [33]. Taken together,
these findings suggest that dysfunction in these areas can
account not only for cognitive deficits, but also for the
misperception of sleep quality in OSA patients.
There is other evidence to support hypoxemia-related
misperception. Exposure to normobaric hypoxia re-
duces neural activity and slows conduction velocity in
the sensor-to-effector pathway of cutaneous warm and
cold sensations [10]. Exposure to hypoxia delays the re-
action time of visual and auditory responses in a dose-
dependent effect [11]. Hypoxia also increases the
threshold of sensation of breathlessness during an exer-
cise challenge and can diminish the perception of dys-
pnea, as well as the magnitude of an externally applied
resistive load [13]. Moreover, hypoxemia stimulates
some inhibitory neurotransmitters, including endogen-
ous opioids, adenosine, and gamma-aminobutyric acid,
which further depress the central nervous system and
attenuate perception [12]. Therefore, in this study, hyp-
oxemia was assumed to play an important role in the
misperception of sleep quality in patients with OSA.
With regard to the effect of hypoxemia, two major char-
acteristics of hypoxemia were considered: time-associated
factors, including frequency or duration of hypoxemia, and
the severity of hypoxemia. Widely used traditional PSG pa-
rameters, including the AHI and ODI, were designed to
assess the frequency of respiratory events. However, de-
tailed information on the severity of hypoxemia was not
available. Therefore, these traditional PSG parameters were
assumed not to be a sensitive predictor for investigating
hypoxemia-related misperception of sleep quality. The
current study showed that these traditional PSG parame-
ters were not correlated with the PSQI total score, as
reported by Scarlata et al. [34].
Although SpO2 can reflect the severity of hypoxemia,
some problems need to be resolved. First, there may be
measurement errors of SpO2 detected from pulse oximetry.
To minimize this error, detected SpO2 was replaced with
data one second before it if SpO2 abruptly changed > 4 %
compared with baseline. Second, the same value of de-
tected SpO2 by pulse oximetry may not represent the same
severity of insufficient oxygenation in different patients be-
cause the detected SpO2 may be affected by the patient’s
skin color and peripheral circulation. Therefore, we focused
on the amplitude of desaturation rather than the absolute
value of SpO2 in this study to minimize the inter-rater dif-
ference of detected SpO2. Third, responses to hypoxemia
vary according to the individual. Hypoxemia with a desat-
uration of 10 % may result in a profound effect on diseased
elderly people, whereas hypoxemia with the same desatur-
ation may only cause a mild effect on healthy young people.
Considering individualized responses to hypoxemia, we
calculated saturation-related parameters by percentile rank.
Furthermore, we used the average value of the lowest and
highest 5 % of the SpO2 series (lowest 5 % SpO2 and high-
est 5 % SpO2) to avoid outliers and fluctuation of SpO2.
T90, another widely used parameter, represents the
duration of severe hypoxemia. However, the problems of
Table 3 Multiple linear regression (stepwise with mixed entry)
Term Coefficient SE Lower 95 % Upper 95 % p-value
Intercept 12.866 2.000 8.913 16.818 <.0001
C-age (years) 0.053 0.023 0.007 0.099 0.025*
C-total sleep time (mins) −0.010 0.005 −0.021 0.001 0.064
PLMI (/hr) 0.618 0.385 −0.142 1.378 0.110
Tendency of depression 2.378 0.636 1.120 3.635 <.0001*
C-lowest 5 % SpO2 (%) −0.263 0.128 −0.516 −0.009 0.042*
Median SpO2-Lowest 5% SpO2 −0.357 0.145 −0.644 −0.070 0.015*
*p < 0.05
Abbreviations: C-age centering of age (age minus the mean of age); C-total sleep time centering of total sleep time (total sleep time minus the mean of total sleep
time); C-lowest 5 % SpO2 centering of the averaged value from the lowest 5 % saturation of total sleep time (lowest 5 % SpO2 minus the mean of lowest 5 % SpO2).
These centering were performed since collinearity was diagnosed; PLMI periodic leg movements index; tendency of depression was defined as either CES-D ≥15 or
HADS-D ≥ 8; median SpO2-lowest 5 % SpO2 difference between median to lowest 5 % of saturation of total sleep time. Median SpO2 minus Lowest 5 % SpO2 was the
independent predictor for lower PSQI after adjusting other variables
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absolute values of SpO2 and individualized responses to
hypoxemia may persist. Additionally, whether SpO2 of
90 % is the most appropriate cutoff value for perceived
sleep quality needs to be carefully considered because
the time spent with saturation < 95 % is correlated with
other physiological changes in OSA patients [35]. The
current study showed that T90 was not correlated with
the PSQI. We speculate that T90 may not be a sensitive
predictor for misperception of sleep quality.
By analyzing the relationship between the PSQI and
saturation-related parameters, our study showed that
more severe hypoxemia was associated with better per-
ceived sleep quality. However, the effect of hypoxemia on
perceived sleep quality did not appear to be significant in
relatively mild hypoxemia, but become significant if the
hypoxemia was severe. Similar results have been reported
in previous studies which showed that the effects of hyp-
oxemia, measured either by visual or auditory reaction
time, are not profound until saturation is below the
threshold [11]. The correlation between hypoxemia and
perceived sleep quality does not appear to be linear and a
threshold of hypoxemia may exist. Therefore, saturation-
related parameters, such as “median SpO2 minus lowest
5 % SpO2” may be better predictors of the effect of hypox-
emia on patients with OSA.
Few studies have focused on the perception of sleep
quality in OSA patients but the results remain inconclu-
sive. Some studies have shown similar findings to the
current study. Krakow et al. demonstrated that OSA pa-
tients complaining of insomnia or poor sleep quality
had a lower AHI compared with those with better sub-
jective sleep quality [36]. Krell et al. showed that pa-
tients with a higher AHI presented with less insomnia
than patients without significant sleep-disordered
breathing [37]. Gooneratne et al. also showed a higher
AHI in patients without sleep complaints (79 %) than in
those with sleep problem (62.6 %) [38]. However, in
these studies, the patients were simply divided into
groups with and without sleep complaints by subjective
definitions [13, 36–38].
Other studies have shown contradictory findings. Smith
et al. showed no correlation between severity of OSA and
the perception of sleep quality, measured by either the
PSQI or subjective complaints [39]. However, there were
no adjustments for possible confounding factors in these
studies. In contrast to previous studies, our study used the
validated Chinese version of the PSQI to quantify subject-
ive sleep quality and conducted multivariable analysis to
adjust for confounding factors.
This study has some limitations. Even though PSG is a
standard diagnostic tool for OSA, one night of PSG may
not precisely represent the severity of OSA because of
night-to-night variability of the AHI. In addition, the PSQI
is designed to represent subjective sleep quality one month
before filling in the scale, whereas PSG only represents
data on the night of examination. Whether PSG data are
correlated with PSQI scores warrants further investigation.
Also, this study is retrospective in nature, and thus a con-
trol group was not available. Furthermore, comorbid med-
ical or neurological disorders that may disturb sleep quality
were excluded based on the selection criteria, which may
have affected generalization of our results.
Conclusions
This study suggests a paradox of better perceived sleep
quality among OSA patients with more severe hypoxemia,
and this may be associated with hypoxemia-related im-
pairment of perception. The effect of hypoxemia does not
appear to be significant unless the saturation is below a
particular threshold, which means that traditional PSG pa-
rameters, such as the AHI and ODI, are insensitive for
predicting the effect of hypoxemia. Nonetheless, further
studies are necessary to confirm the role of hypoxemia on
perception of sleep quality and identify the possible
threshold of hypoxemia in OSA patients.
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